Koyfin Home > Directory > Health Care > Abiomed Inc > EBITDA Margin

Abiomed Inc EBITDA Margin Chart (ABMD)

Abiomed Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Abiomed Inc EBITDA Margin for the quarter ending September 09, 2020 was $32m a -6.03% decrease of -2m year over year
  • Abiomed Inc EBITDA Margin for the last 12 months ending September 09, 2020 was $31m a -5.82% decrease of -2m year over year
  • Abiomed Inc Annual EBITDA Margin for 2020 was $32m a 3.33% increase of 1m from 2019
  • Abiomed Inc Annual EBITDA Margin for 2019 was $31m a 7.73% increase of 2m from 2018
  • Abiomed Inc Annual EBITDA Margin for 2018 was $29m a 22.95% increase of 7m from 2017
Other Margins & Efficiency Metrics:
  • Abiomed Inc Return on Capital % for the quarter ending December 12, 2018 was 18.96 a 5.11% increase of 0.97 year over year
  • Abiomed Inc Return on Equity % for the quarter ending December 12, 2018 was 21.82 a -2.17% decrease of -0.47 year over year
View Chart On Koyfin

Quarterly ABMD EBITDA Margin Data

09/2020$32m
06/2020$25m
03/2020$30m
12/2019$34m
09/2019$32m
06/2019$32m
03/2019$33m
12/2018$33m
09/2018$30m
06/2018$28m

Annual ABMD EBITDA Margin Data

2020$32m
2019$31m
2018$29m
2017$22m
2016$21m
2015$14m
2014$6m
2013$12m
2012$5m
2011$-7m